<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Chinese Journal of Magnetic Resonance Imaging RSS feed</title>
<link>http://med-sci.cn/cgzcx/en/contents_list.asp?issue=202607</link>
<language>zh-cn</language>
<copyright>An RSS feed for Chinese Journal of Magnetic Resonance Imaging</copyright>
<item>
<title><![CDATA[GluCEST imaging and structural changes in bilateral thalami of epileptic children with negative conventional MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.001</link>
<description><![CDATA[<b>Objective</b>The glutamate-weighted chemical exchange saturation transfer (GluCEST) imaging technique was used to evaluate the changes of glutamate (Glu) in the thalamus of children with negative MRI - confirmed epilepsy. Furthermore, the volume changes of the subregions of the thalamus in these children were explored, and the correlation between the Glu changes measured by GluCEST and the volume of the thalamic subregions was analyzed. <b>Materials and Methods</b>A total of 73 pediatric patients diagnosed with epilepsy were prospectively enrolled between January 2024 and May 2026 at the Department of Pediatric Neurology, Binzhou Medical University Hospital. They were divided into the focal epilepsy (FE) group with 37 cases and the generalized epilepsy (GE) group with 36 cases. Thirty-six healthy control (HCs) subjects were recruited. The brain magnetic resonance images of the three groups were collected to exclude data with brain diseases. Those meeting the requirements were subjected to three-dimensional T1-weighted magnetization prepared rapid gradient echo (MPRAGE) imaging and GluCEST imaging. The GluCEST images were processed using Matlab software to obtain the asymmetric magnetization rate (MTR<sub>asym</sub>) value of the thalamus region, representing the relative Glu concentration value of this area; the MPRAGE images were automatically segmented using FreeSurfer to obtain the volume of the thalamic subregions. SPSS was used to compare the MTR<sub>asym</sub> values of the left and right thalamus in the three groups, and to compare the thalamic MTR<sub>asym</sub> values and subregion volumes between the GE group and the HCs group, as well as between the FE group and the HCs group. <b>Results</b>The MTR<sub>asym</sub> value of the ipsilateral thalamus in the focal epilepsy (FE) group was significantly higher than that of the contralateral thalamus, with a statistically significant difference (<i>t </i>= 3.252, <i>P</i> = 0.002). In the generalized epilepsy (GE) group, both the left (<i>Z</i> = -4.944, <i>P </i>&lt; 0.001) and right (<i>t </i>= 4.816, <i>P </i>&lt; 0.001) thalamic MTR<sub>asym</sub> values were significantly elevated compared to those in the healthy control (HC) group. Similarly, both the ipsilateral (<i>t </i>= 4.547, <i>P</i> &lt; 0.001) and contralateral (<i>t </i>= 3.293, <i>P</i> = 0.002) thalamic MTR<sub>asym</sub> values in the FE group were significantly higher than those in the HC group. Regarding thalamic subregion volumes, the volume of the right medial nucleus in the GE group was significantly smaller than that in the HC group (<i>t </i>= -2.667, <i>P</i> = 0.009); however, no significant differences were observed between the FE group and the HC group in any thalamic subregion (<i>P</i> &gt; 0.05). Furthermore, no significant correlation was found between thalamic MTR<sub>asym</sub> values and the volumes of thalamic subregions in either the GE or FE groups (<i>P</i> &gt; 0.05). <b>Conclusions</b>This study employed GluCEST imaging in conjunction with structural MRI to investigate glutamate concentration and volumetric alterations in the thalamus among children with epilepsy and negative conventional MRI findings. Furthermore, the correlation between MTR<sub>asym</sub> values and the volumes of specific thalamic subregions was examined. It is helpful to understand the neuro-metabolic differences of different types of epilepsy, and it opens up a new perspective for the diagnosis, treatment and prognosis of children with epilepsy. GluCEST technology is expected to provide a new, non-invasive imaging tool for exploring the pathophysiological mechanism of childhood epilepsy. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Meta-analysis of gray matter volume and resting-state functional connectivity in type 2 diabetes-related cognitive impairment]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.002</link>
<description><![CDATA[<b>Objective</b>To investigate structural and functional brain alterations in type 2 diabetes mellitus-associated cognitive dysfunction (TDACD) and to explore potential neural mechanisms. <b>Materials and Methods</b>This study has been registered on the Prospective Register of Systematic Reviews (PROSPERO) with the registration number CRD420251115489. Whole-brain voxel-based morphometry (VBM) and resting-state functional magnetic resonance imaging (rs-fMRI) studies were systematically identified and selected according to PRISMA guidelines. A meta-analysis of gray matter volume (GMV) and resting-state functional connectivity (rs-FC) was conducted using seed-based d mapping with permutation of subject images (SDM-PSI), together with sensitivity, heterogeneity, and publication bias testing. Meta-regression analyses were additionally conducted using demographic and clinical variables [age, sex, body mass index (BMI), education, disease duration, glycated hemoglobin A1c (HbA1c), Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA)]. <b>Results</b>Twelve studies (7 functional and 5 structural) were included. Compared with healthy controls (HC), patients with TDACD demonstrated reduced functional activity in the left supramarginal gyrus [SMG, MNI coordinates: (-54, -54, 28), SDM-<i>Z</i> = -4.678, <i>P</i> &lt; 0.000 5] and right inferior frontal gyrus, orbital part [IFGorb, MNI coordinates: (48, 40, -4), SDM-<i>Z</i> = -3.649, <i>P</i> &lt; 0.001)], accompanied by significant gray matter volume reduction in the right putamen [PUT, MNI coordinates: (34, -4, 4), SDM-<i>Z</i> = -2.933, <i>P</i> &lt; 0.01]. Sensitivity analyses confirmed the robustness of these findings. Higher levels of education were associated with milder functional impairment in the right IFGorb (<i>r </i>= 0.558, <i>P </i>&lt; 0.005), whereas no other variables showed significant moderating effects. <b>Conclusions</b>Patients with TDACD exhibit structural and functional abnormalities in the cortical-subcortical circuits; in particular, damage to core brain regions centered on the PUT-SMG-IFGorb may constitute a potential neuroimaging biomarker. These findings provide important clues for the pathological mechanisms, early identification, and neuromodulation interventions of TDACD. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Assessing glymphatic system dysfunction based on the DTI-ALPS method and choroid plexus remodeling in neuropsychiatric systemic lupus erythematosus: A correlation study]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.003</link>
<description><![CDATA[<b>Objective</b>To investigate the characteristics of glymphatic system dysfunction and choroid plexus (ChP) morphological remodeling in patients with neuropsychiatric systemic lupus erythematosus (NPSLE) using diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) and deep learning-based ChP segmentation, and to further explore their correlations with disease activity. <b>Materials and Methods</b>This prospective cross-sectional study included 47 patients with NPSLE and 59 concurrently recruited healthy controls between December 2023 and October 2025. All participants underwent conventional magnetic resonance imaging, high-resolution 3D T1-weighted imaging, and diffusion tensor imaging (DTI). The DTI-ALPS index was calculated to quantitatively evaluate glymphatic clearance. Furthermore, a 3D U-Net model was utilized to automatically segment the ChP of the lateral ventricles and quantify its volume. Partial correlation analyses, adjusting for age, years of education, and total intracranial volume, were performed to assess the associations between these neuroimaging metrics and the SLE Disease Activity Index (SLEDAI) score, Montreal Cognitive Assessment (MoCA) score, and disease duration. <b>Results</b>Compared to healthy controls, patients with NPSLE exhibited significantly reduced left DTI-ALPS indices (<i>F</i> = 6.235, <i>P</i> = 0.014), right DTI-ALPS indices (<i>F</i> = 10.168, <i>P</i> = 0.002) and global mean DTI-ALPS indices <i>(F</i> = 9.764, <i>P</i> = 0.002), and concomitantly increased left normalized ChP volume ratio (<i>F</i> = 9.532, <i>P </i>= 0.003), right normalized ChP volume ratio<i> (F = </i>9.153<i>, P = </i>0.003), and total normalized ChP volume ratio (<i>F</i> = 11.208, <i>P </i>= 0.001). Correlation analysis showed that, in the NPSLE group, the mean DTI-ALPS index was negatively correlated with the SLEDAI score (<i>r</i> = -0.436, <i>P </i>= 0.003), whereas there were no significant correlations between the mean DTI-ALPS index and the normalized ChP volume ratio, nor between these two parameters and disease duration or MoCA score (all <i>P</i> &gt; 0.05). <b>Conclusions</b>NPSLE patients exhibit glymphatic dysfunction and ChP morphological remodeling, and DTI-ALPS, which is closely correlated with SLEDAI, may serve as an imaging biomarker for monitoring central nervous system involvement and assessing disease fluctuation. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Graph-theoretical comparison of brain network topology during motor imagery and motor execution]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.004</link>
<description><![CDATA[<b>Objective</b>To compare the topological properties of brain networks during right-hand motor execution and motor imagery in healthy individuals, and to explore the neural mechanisms underlying the two motor conditions. <b>Materials and Methods</b>Forty right-handed healthy volunteers underwent task-based functional magnetic resonance imaging. Whole-brain functional connectivity matrices were constructed using the Schaefer 2018 atlas (17-network parcellation). The left somatomotor network and its subnetworks (A and B) were extracted. Graph-theoretical methods were used to calculate network density, global efficiency, nodal efficiency, clustering coefficient, and betweenness centrality at the module-internal and module-to-whole-brain levels. Paired <i>t</i>-tests were performed, with false discovery rate (FDR) correction applied for multiple comparisons. <b>Results</b>Compared with motor execution, motor imagery showed increased network density, global efficiency, and betweenness centrality among the module-to-whole-brain metrics in the left somatomotor network A (<i>t </i>= 4.272, 4.280, and 8.981; <i>P </i>= 0.004, 0.004, and &lt; 0.001, respectively; FDR-corrected), and decreased nodal efficiency and clustering coefficient (<i>t </i>= -3.867 and -4.107; <i>P </i>= 0.009 and 0.005, respectively; FDR-corrected). In the left somatomotor network B, network density, global efficiency, and betweenness centrality among the module-to-whole-brain metrics were also increased during motor imagery (<i>t </i>= 3.403, 3.217, and 4.543; <i>P </i>= 0.022, 0.029, and 0.003, respectively; FDR-corrected). <b>Conclusions</b>Motor imagery and motor execution showed distinct brain network topological patterns within the left somatomotor network, and the left somatomotor networks A and B responded differently to the two task conditions. This finding may provide imaging evidence for understanding the differences in neural mechanisms between motor imagery and motor execution. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Functional brain activity alterations in acute leukemia: An activation likelihood estimation meta-analysis of fMRI studies]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.005</link>
<description><![CDATA[<b>Objective</b>To identify consistent alterations in brain functional activity in patients with acute leukemia (AL) compared with healthy controls (HCs) using functional magnetic resonance imaging (fMRI) and the activation likelihood estimation (ALE) meta-analytic approach, and to explore the potential neurobiological mechanisms underlying these changes. <b>Materials and Methods</b>This study was prospectively registered in PROSPERO (CRD42025117006). A systematic search was conducted for studies published before October 16, 2025, that used task-based or resting-state fMRI to investigate brain functional alterations in AL patients. Eligible studies were selected according to predefined inclusion and exclusion criteria. The ALE meta-analysis was performed using the GingerALE software with cluster-level family-wise error (cFWE) correction, and the results were visualized using Mango software. The reproducibility of the findings was further assessed using Jackknife sensitivity analysis and cluster-level reproducibility analysis. <b>Results</b>Seven studies were included, comprising 102 AL patients and 96 HCs. Among them, six studies involved acute lymphoblastic leukemia (ALL) and one study involved acute myeloid leukemia (AML). Compared with HCs, AL patients exhibited significantly decreased activation in the left postcentral gyrus, left inferior parietal lobule, left middle frontal gyrus, left lingual gyrus, and right cerebellar culmen (<i>P</i> &lt; 0.05, cluster volume = 1088 - 1672 mm<sup>3</sup>). These clusters were reproduced in 4, 4, 4, 3, and 3 of 5 Jackknife analyses, respectively. Conversely, increased activation was observed in the right cerebellar tonsil (<i>P</i> &lt; 0.05, cluster volume = 1760 mm<sup>3</sup>), which remained significant across all 5 Jackknife iterations. <b>Conclusions</b>The ALE meta-analysis revealed abnormal functional activity in key brain regions, including the somatosensory cortex, frontal lobe, occipital lobe, and cerebellum, in patients with AL. These findings provide neuroimaging evidence for AL-related brain functional alterations and may facilitate a better understanding of AL-related brain dysfunction. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Prediction of MGMT methylation status in glioblastoma using DTI and ASL histogram features and its association with prognosis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.006</link>
<description><![CDATA[<b>Objective</b>To explore the value of histogram parameters derived from diffusion tensor imaging (DTI) and arterial spin labeling (ASL) in the non-invasive preoperative prediction of the promoter methylation status of O<sup>6</sup>-methylguanine-DNA methyltransferase (MGMT), and to further analyze their correlation with patients<sup><sup>,</sup></sup> survival and prognosis. <b>Materials and Methods</b>We retrospectively analyzed DTI and ASL data from 349 patients with IDH-wildtype glioblastoma. Histogram parameters—including fractional anisotropy (FA), mean diffusivity (MD), and cerebral blood flow (CBF)—were extracted. Binary logistic regression models were built using DTI parameters, ASL parameters, and their combination. Patients were divided into two groups based on MGMT promoter methylation status (methylated vs. unmethylated), and comparisons were made between groups. Model performance was assessed using receiver operating characteristic (ROC) curves, calibration curves, and the Hosmer-Lemeshow goodness-of-fit test. For survival analysis, we performed Kaplan-Meier analysis and used both univariate and multivariate Cox regression to examine associations between imaging features, molecular markers, and overall survival (OS). Bootstrap mediation analysis was conducted to test whether specific imaging parameters mediate the relationship between MGMT methylation status and survival. <b>Results</b>The DTI model (AUC = 0.842) significantly outperformed the ASL model (AUC = 0.619) in predicting MGMT methylation status. The combined DTI-ASL model (AUC = 0.859) was not significantly different from the DTI model alone (<i>Z</i> = 0.53, <i>P</i> = 0.593). Kaplan-Meier analysis confirmed that MGMT promoter methylation was a significant protective factor for prognosis (Log-rank <i>P</i> = 0.041, HR = 0.737, 95% <i>CI</i>: 0.550 to 0.989). However, Cox regression showed that although imaging parameters were significantly associated with MGMT methylation status, they were not independent predictors of OS. Mediation analysis revealed that the 10th percentile of FA mediated the relationship between MGMT methylation status and OS. Skewness of MD showed a statistical association with both factors but its mediation effect was not significant. <b>Conclusions</b>DTI histogram parameters serve as effective noninvasive imaging markers for predicting MGMT promoter methylation before surgery. The 10th percentile of FA is a key imaging factor linking unmethylated MGMT status to poor prognosis. MD skewness is statistically associated with this link, suggesting that disruption of tumor microstructure and increased tissue heterogeneity may mediate the effect of MGMT methylation status on patient outcomes. These findings offer a new imaging-based perspective for understanding the aggressive biological behavior of glioblastoma. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Hemodynamic characterization of left ventricular thrombus in myocardial infarction patients based on 4D Flow MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.007</link>
<description><![CDATA[<b>Objective</b>This study aimed to assess the left ventricular hemodynamic characteristics in patients with myocardial infarction (MI) and left ventricular thrombus (LVT) using four-dimensional flow magnetic resonance imaging (4D Flow MRI), and to explore their potential relationship with LVT formation. <b>Materials and Methods</b>A total of 45 subjects were enrolled, including 15 subjects in each group: MI with LVT [MI-LVT(+)], MI without LVT [MI-LVT(-)], and healthy controls. All participants underwent steady-state free precession and 4D Flow MRI scans. Left ventricular functional parameters, four flow components (direct flow, retained inflow, delayed ejection flow, and residual volume), and kinetic energy (KE) parameters, including global KE, peak systolic KE, systolic KE, diastolic KE, E-wave and A-wave peak KE, were quantitatively analyzed using MASS software. All KE parameters were normalized to left ventricular end-diastolic volume (LVEDV)  (denoted as KEi<sub>EDV</sub>). Myocardial scar extent was assessed using CVI.42 software. Binary logistic regression analysis was used to identify variables independently associated with the presence of LVT, and receiver operating characteristic (ROC) curves were employed to evaluate the diagnostic performance of 4D Flow MRI parameters. <b>Results</b>Compared with healthy controls, MI patients exhibited significant left ventricular remodeling, with increased left ventricular end-diastolic volume index (LVEDVi) and left ventricular end-systolic volume index (LVESVi) and decreased left ventricular ejection fraction (LVEF) (all <i>P</i> &lt; 0.001). LVEF was lower in the MI-LVT(+) group compared with the MI-LVT(-) group (31% vs. 40%, <i>P</i> = 0.034). MI patients showed significantly reduced direct flow (<i>P</i> &lt; 0.001) and increased residual volume (<i>P</i> &lt; 0.001), with more pronounced changes observed in the MI-LVT(+) group (<i>P</i> &lt; 0.05). All KEi<sub>EDV</sub> parameters were significantly reduced in the MI group (all <i>P</i> &lt; 0.001); however, no statistically significant differences were found between the LVT subgroups. Logistic regression analysis showed that direct flow was independently associated with the presence of LVT. ROC curve analysis demonstrated an area under the  curve of 0.747, with an optimal cutoff value of 16.24%, a sensitivity of 80.00%, and a specificity of 66.67%. <b>Conclusions</b>MI patients demonstrated notable LV remodeling and hemodynamic abnormalities compared to healthy controls. Reduced direct flow and increased residual flow were key characteristics, especially in patients with LVT. Overall KE parameters were decreased, especially in the MI-LVT(+) group. Direct flow is independently associated with the presence of LVT and can serve as a supplementary tool to conventional structural assessment, assisting clinicians in multi-dimensional risk stratification. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Cardiac magnetic resonance tissue characteristics and their association with systemic inflammation in acute Takotsubo cardiomyopathy: A longitudinal quantitative study]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.008</link>
<description><![CDATA[<b>Objective</b>To systematically evaluate whether acute Takotsubo cardiomyopathy is accompanied by both myocardial tissue-level inflammatory changes and systemic inflammatory activation, and to investigate their correspondence and temporal evolution using cardiac magnetic resonance (CMR) tissue characterization combined with serum cytokine profiling. <b>Materials and Methods</b>Forty-two patients with acute Takotsubo cardiomyopathy and 29 healthy controls were enrolled. All participants underwent CMR with acquisition of native T1 mapping, native T2 mapping, and extracellular volume (ECV) for myocardial tissue characterization, along with left ventricular functional assessment. Patients received follow-up CMR at 3 and 6 months. Concurrent measurements included cardiac injury biomarkers, NT-proBNP, and multiple cytokines (IL-1β, IL-6, IL-8, IL-10, MCP-1, TNF-α, IFN-γ). Acute-phase and follow-up changes in tissue parameters and inflammatory markers were compared, and correlations between acute values and longitudinal changes were analyzed. <b>Results</b>Patients in the acute phase exhibited significantly elevated native T1 and T2 (both <i>P</i> &lt; 0.05), indicating diffuse myocardial edema, with the largest increases observed in ballooning segments. Both T1 and T2 declined significantly during recovery (both<i> P</i> &lt; 0.05), although ECV remained elevated at 6 months in a subset of patients. Left ventricular ejection fraction improved over time, accompanied by reductions in end-systolic volume index and myocardial mass index (both <i>P</i> &lt; 0.01). IL-6, IL-8, and MCP-1 were elevated in the acute phase, and their declines showed moderate positive correlations with improvements in T1/T2 (all <i>P</i> &lt; 0.05), indicating parallel changes between myocardial abnormalities and systemic inflammation with temporal correspondence during recovery. TNF-α, IFN-γ, and IL-10 did not rise acutely and remained stable throughout follow-up, suggesting a non-necrotic and non-severe inflammatory phenotype in Takotsubo cardiomyopathy. <b>Conclusions</b>Acute Takotsubo cardiomyopathy is characterized by marked myocardial edema and elevations in proinflammatory cytokines. Although most imaging and inflammatory abnormalities improve during the recovery phase, residual structural alterations persist in some patients, indicating that inflammation-related myocardial injury may not be fully reversible. Accordingly, CMR combined with cytokine profiling provides valuable tools for assessing myocardial edema, changes in quantitative tissue parameters, and inflammatory responses, as well as for dynamically tracking the recovery process in Takotsubo cardiomyopathy. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[A study of an MRI-based radiomics and deep learning model for predicting axillary lymph node metastasis in breast cancer with 1 to 2 positive sentinel lymph nodes]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.009</link>
<description><![CDATA[<b>Objective</b>To evaluate the clinical value of magnetic resonance imaging (MRI)-based radiomics and deep learning (DL) features in predicting axillary lymph node (ALN) status in breast cancer patients with 1 to 2 positive sentinel lymph nodes (SLNs). <b>Materials and Methods</b>We retrospectively analyzed clinicopathological and MRI data from breast cancer patients with pathologically confirmed 1 to 2 positive SLNs at our institution between January 2017 and December 2024. The tumor regions of interest (ROIs) were manually delineated on diffusion-weighted imaging (DWI) and third-phase dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) images using ITK-SNAP 3.8.0 software. Radiomics features were extracted using PyRadiomics, and DL features were extracted using a pretrained Inception-v3 model. Features strongly associated with ALN metastasis were selected using statistical tests, minimum redundancy maximum relevance (mRMR), Spearman correlation analysis, and the least absolute shrinkage and selection operator (LASSO) algorithm. Clinicopathological risk factors associated with ALN metastasis were identified using multivariate logistic regression analysis. Radiomics model, DL model, deep learning radiomics (DLR) model, clinical model and combined model incorporating clinical features were constructed to predict ALN status. The area under the curve (AUC), sensitivity, specificity, and accuracy were calculated to evaluate model performance. Decision curve analysis was performed to assess clinical utility. <b>Results</b>A total of 256 patients were enrolled, with 105 patients in the ALN-positive group and 151 in the ALN-negative group. Logistic regression analysis demonstrated that maximum tumor diameter, lymphovascular invasion (LVI), and the number of positive SLNs were independent risk factors for ALN metastasis (all <i>P </i>&lt; 0.05). In the validation cohort, the DLR model achieved an AUC of 0.800 (95% <i>CI: </i>0.661 to 0.909), outperforming the radiomics model (AUC = 0.734, 95% <i>CI: </i>0.580 to 0.861) and the DL model (AUC = 0.774, 95% <i>CI:</i> 0.632 to 0.903). The combined model incorporating clinical features showed optimal performance, achieving an AUC, sensitivity, specificity, and accuracy of 0.851 (95% <i>CI: </i>0.722 to 0.953), 76.2%, 90.3%, and 84.6%, respectively. It also achieved a higher clinical net benefit within a reasonable threshold probability range. <b>Conclusions</b>Multiparametric MRI-based radiomics, DL, and DLR models can assist in assessing the risk of ALN metastasis in breast cancer patients with 1 to 2 positive SLNs preoperatively. The combined model incorporating clinical features demonstrated favorable clinical utility for comprehensive risk stratification of ALN metastasis after sentinel lymph node biopsy (SLNB). Following further multicenter prospective validation, it may provide auxiliary support for individualized clinical decision-making regarding axillary management. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Analysis of the fat fraction histogram of the brown adipose depot in the supraclavicular region of patients with colorectal cancer based on magnetic resonance mDIXON technology]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.010</link>
<description><![CDATA[<b>Objective</b>To quantitatively explore changes in the fat fraction (FF) of the supraclavicular fat depot in patients with colorectal cancer using the MRI multi-echo DIXON (mDIXON) technique. <b>Materials and Methods</b>Newly diagnosed colorectal cancer patients (<i>n</i> = 60) were prospectively recruited and underwent neck MRI mDIXON. Neck mDIXON images from healthy volunteers (<i>n</i> = 60) during the same period were collected as controls. Representative region of interest for brown adipose tissue (BAT) in the supraclavicular fat depot and region of interest for white adipose tissue (WAT) in the dorsal subcutaneous fat at the same level were manually delineated on the mDIXON-FF images of both groups, avoiding blood vessels, nerves, and edge areas. Histogram features were extracted. Two independent samples <i>t</i>-tests (for normal parameters) or Mann-Whitney <i>U</i> tests (for non-normal parameters) were used to compare the FF histogram features between the two groups. Colorectal cancer patients were further subdivided based on pathological or clinical characteristics (such as tumor staging, whether there is lymph node metastasis, etc.). Propensity score matching was used to control for confounding factors like age, gender, and body mass index, and the FF histogram features were compared between the matched subgroups. In addition, 10 healthy volunteers were recruited. MRI mDIXON images of their necks were collected before and after a 30-day interval to evaluate the measurement stability of BAT in the supraclavicular fossa and subcutaneous WAT. The manual delineation of the ROI was also tested for its repeatability. Finally, the consistency of delineating BAT ROIs on the left and right sides of the supraclavicular fat depot was verified. <b>Results</b>Histogram analysis of the supraclavicular fat depot revealed that three features representing FF magnitude [10th Percentile (85.69 vs. 82.59, <i>P</i> &lt; 0.001), Mean (90.24 vs. 86.92, <i>P</i> &lt; 0.001), and Minimum (83.22 vs. 79.71, <i>P</i> &lt; 0.001)] were all significantly higher in the colorectal cancer group compared to the control group. None of the histogram features for subcutaneous white adipose tissue showed statistically significant differences between the two groups. After internal grouping of colorectal cancer patients based on characteristics like lymph node metastasis, significant differences were observed between the lymph node metastasis-negative and positive groups for three features: InterquartileRange (5.27 vs. 3.55, <i>P</i> = 0.048), MeanAbsoluteDeviation (2.83 vs. 1.99, <i>P</i> = 0.029), and RobustMeanAbsoluteDeviation (2.20 vs. 1.45, <i>P</i> = 0.013). No statistically significant differences were observed in other features between the other subgroups. The reproducibility test of manual ROI delineation showed that all the above six features had good consistency [intra-class correlation coefficient (ICC) ≥ 0.75]. The self-control before and after showed that the FF histogram features of supraclavicular BAT and subcutaneous WAT obtained by scanning after 30 days had good stability. There was no significant statistical difference in delineating BAT ROI from the left and right supraclavicular fat depots respectively. <b>Conclusions</b>In patients with colorectal cancer, the relative content of supraclavicular brown adipose tissue (BAT) is decreased and the FF is elevated, suggesting that the reduction in BAT proportion may be accompanied by a decrease in BAT content, and its changes are correlated with disease progression indicators such as lymph node metastasis. Furthermore, the histogram analysis method based on mDIXON-FF provides a non-invasive and stable new approach for assessing brown adipose tissue, showing future potential as an imaging biomarker for metabolic evaluation and prognosis prediction in colorectal cancer. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Predicting lumbar disc degeneration using interpretable machine learning models based on MAGiC and IDEAL-IQ sequences]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.011</link>
<description><![CDATA[<b>Objective</b>To investigate the correlation between multidimensional quantitative parameters derived from the magnetic resonance image compilation (MAGiC) sequence and the iterative decomposition of water and fat with echo asymmetry and least‑squares estimation quantitative (IDEAL‑IQ) sequence with lumbar disc degeneration (LDD), and to construct an interpretable machine learning model for predicting LDD. <b>Materials and Methods</b>A total of 199 volunteers with chronic low back pain were prospectively recruited and divided into a normal group (<i>n</i> = 83) and a degeneration group (<i>n</i> = 116) based on Pfirrmann grading (&gt; grade Ⅱ defined as LDD) on T2‑weighted images. The cohort was randomly split into training and validation sets at a 7∶3 ratio. All participants underwent conventional lumbar MRI, MAGiC, and IDEAL‑IQ sequence scans. Collected data included the vertebral bone quality (VBQ) score calculated from conventional T1‑weighted images, T1 relaxation time (T1), T2 relaxation time (T2), and proton density (PD) values obtained from the MAGiC sequence, the average fat fraction (FFav) measured by the IDEAL‑IQ sequence, as well as general clinical information, laboratory results, and body mass index (BMI). Spearman correlation analysis and logistic regression were used to screen for degeneration‑related predictors. Six machine learning algorithms [logistic regression (LR), decision tree (DT), extreme gradient boosting (XGBoost), support vector machine (SVM), k‑nearest neighbors (KNN), and light gradient boosting machine (LightGBM)] were employed to build prediction models. Model performance was comprehensively evaluated using the receiver operating characteristic (ROC) curve, area under the curve (AUC), accuracy, sensitivity, specificity, F1‑score, positive predictive value (PPV), and negative predictive value (NPV), DeLong test was used to compare the differences in AUC among the models. Clinical net benefit was assessed by decision curve analysis (DCA). The optimal model was interpreted using SHapley Additive exPlanations (SHAP). <b>Results</b>Significant differences were observed between the normal and degeneration groups in age, albumin (ALB), T1, T2, PD, FFav, and VBQ scores (<i>P </i>&lt; 0.05). Disc degeneration showed positive correlations with age, FFav, and VBQ score (<i>r</i> = 0.61, 0.36, 0.39), and negative correlations with ALB, T1, T2, and PD values (<i>r</i> = -0.30, -0.60, -0.70, -0.47). Among the six machine learning models, LightGBM performed best, achieving an AUC of 0.967 (95% <i>CI</i>: 0.942 to 0.993) in the training set, with accuracy of 91.2%, sensitivity of 90.0%, specificity of 93.3%, F1‑score of 0.922, PPV of 94.7%, and NPV of 87.5%. DCA indicated a high clinical net benefit within the medium‑risk threshold range. SHAP analysis further revealed that T2, T1, and age were the key predictors of LDD. <b>Conclusions</b>Machine learning models built on multidimensional quantitative parameters from MAGiC and IDEAL‑IQ sequences can effectively predict LDD, with the LightGBM model demonstrating the best performance. The SHAP method enhances model interpretability, providing a quantitative tool and decision‑making reference for early identification and clinical intervention of LDD. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Value of multiparametric MR black-blood thrombus imaging in staging diagnosis of lower extremity deep vein thrombosis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.012</link>
<description><![CDATA[<b>Objective</b>To investigate the value of combined T1‑weighted and T2‑weighted magnetic resonance black‑blood thrombus imaging (BTI) for staging diagnosis of lower extremity deep vein thrombosis (DVT). <b>Materials and Methods</b>A total of 55 patients with first-diagnosed DVT underwent T1-BTI and T2-BTI scanning of the lower extremity deep veins and were divided into acute (<i>n</i> = 29), subacute (<i>n</i> = 13), and chronic (<i>n</i> = 13) stages based on comprehensive clinical diagnosis. On T1-BTI and T2-BTI images, the signal intensity ratio (SIR) at the proximal and distal ends of the thrombus (proximal T1-SIR, proximal T2-SIR, distal T1-SIR, distal T2-SIR, denoted as pT1-SIR, pT2-SIR, dT1-SIR, dT2-SIR, respectively), lumen area ratio, and soft tissue edema score (0 to 3) were measured. Differences in each indicator between acute and subacute stages, as well as between acute and chronic stages, and the diagnostic performance of individual and combined indicators in the above differential scenarios were compared. <b>Results</b>In differentiating acute from subacute DVT, acute-stage pT1-SIR, pT2-SIR, dT1-SIR, and dT2-SIR were all lower than those in subacute stage (all <i>P</i> &lt; 0.05); soft tissue edema score was higher in acute stage (<i>P</i> = 0.037); there was no significant difference in lumen area ratio between groups (<i>P</i> = 0.591). Among single indicators, pT1-SIR had the highest area under the curve (AUC) of 0.944 [95% confidence interval (<i>CI</i>): 0.871 to 1.000], with a sensitivity of 89.7% and specificity of 92.3% for diagnosing acute stage using a cutoff value of ≤1.23. The AUC of pT1-SIR combined with soft tissue edema score was 0.968 (95% <i>CI</i>: 0.911 to 1.000), with a sensitivity of 93.1% and specificity of 100%; the AUC of pT1-SIR combined with dT2-SIR was 0.963 (95% <i>CI</i>: 0.912 to 1.000), with a sensitivity of 86.2% and specificity of 100%. There were no statistically significant differences in AUC between either combined model and single pT1-SIR (both <i>P</i> &gt; 0.05). In differentiating acute from chronic DVT, there were no statistically significant differences in SIR indicators between groups (<i>P</i> &gt; 0.05). Lumen area ratio and soft tissue edema score in acute DVT were significantly higher than those in chronic DVT (<i>P</i> &lt; 0.001). The AUC of soft tissue edema score was 0.996 (95% <i>CI</i>: 0.984 to 1.000), with a sensitivity of 96.6% and specificity of 100% for diagnosing acute stage using a cutoff value of ≥ 1.5; the AUC of lumen area ratio was 0.862 (95% <i>CI</i>: 0.723 to 1.000). <b>Conclusions</b>Combined T1-BTI and T2-BTI can reflect the course of DVT from the two dimensions of thrombus signal and soft tissue edema. Soft tissue edema score has high diagnostic efficacy in ruling out chronic DVT; pT1-SIR is helpful in differentiating acute from subacute DVT, and combined assessment shows good diagnostic performance, but the incremental value compared with single pT1-SIR needs further validation in large-sample studies. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Mechanism of intracranial tuberculous granuloma in rats based on MRI tracer technology]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.013</link>
<description><![CDATA[<b>Objective</b>To establish a brain tuberculous granuloma model in Sprague-Dawley (SD) rats through BCG vaccination, and investigate the changes in the extracellular space (ECS) of brain tuberculous granulomas and the tracer distribution and clearance. <b>Materials and Methods</b>Forty SD rats were used. Thirty rats were randomly selected to establish a brain tuberculosis granuloma model by stereotactic injection of BCG suspension into the caudate nucleus of the rats, while the remaining ten received saline injections at the same site to serve as the control group. Four weeks after modeling, MRI scans were performed to observe granuloma formation. Rats in the tuberculosis granuloma model group and the saline group underwent tracer-based MRI scans with gadolinium-diethylene triamine pentaacetic acid (Gd-DTPA) as the contrast agent. Ten rats in the tuberculosis granuloma group meeting the inclusion criteria (intracranial tuberculosis granulomas confirmed by pathology) and eight rats in the saline group were used for parameter measurement on tracer-based imaging (effective diffusion coefficient D<sup>*</sup>, volume fraction α, clearance rate constant K, and half-life T<sub>1/2</sub>). The ECS parameters of the two groups were compared to analyze changes in the ECS and its mechanism. <b>Results</b>A brain tuberculosis granuloma model was established using 1×10<sup>6</sup> CFU/mL BCG suspension, and four weeks after modeling, the formation rate of tuberculosis granulomas in rats was 56.7% (17/30). Experimental results showed that compared with the saline group, the brain tuberculosis granuloma model group exhibited significant changes in multiple ECS parameters: the clearance rate (K) in the granuloma model group was lower than that in the saline group (K: <i>P </i>= 0.006), while the diffusion coefficient (D<sup>*</sup>), half-life (T<sub>1/2</sub>), and volume fraction (α) were all higher than those in the saline group (D<sup>*</sup>: <i>P </i>= 0.024;T<sub>1/2</sub>:<i>P </i>= 0.011;α: <i>P </i>= 0.029). <b>Conclusions</b>A brain tuberculosis granuloma model in SD rats can be established using a BCG bacterial suspension at a dose of 1×10<sup>6</sup> CFU/mL. Due to cell necrosis and matrix remodeling, the ECS structure in the granuloma area is altered, allowing tracers to diffuse faster and over a wider range. However, the structural barrier of the granuloma wall obstructs local drainage, leading to prolonged tracer retention. MRI tracer techniques can effectively monitor the morphological and functional changes of the ECS under pathological conditions, providing a theoretical basis for drug delivery via the ECS. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in MRI research on cognitive impairment in type 1 diabetes]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.014</link>
<description><![CDATA[Type 1 diabetes mellitus (T1DM) is associated with alterations in brain structure and function, which have been linked to cognitive decline. In recent years, MRI has provided important evidence for elucidating the neural basis of T1DM-related cognitive dysfunction. Previous studies have shown that patients with T1DM may exhibit changes in gray matter volume or cortical thickness, white matter microstructural damage, abnormal cerebral perfusion, and altered resting-state neural activity and functional connectivity. These abnormalities may become more pronounced with longer T1DM duration. This review summarizes the potential mechanisms underlying T1DM-related cognitive impairment and its neuroimaging markers, with a focus on structural imaging, diffusion imaging, cerebral perfusion imaging, and functional MRI. It also discusses current research limitations and future directions. By integrating evidence across these imaging modalities, this review aims to provide a systematic neuroimaging evidence framework for studies of the neural mechanisms of T1DM-related cognitive dysfunction and to offer insights into early identification and potential intervention targets for high-risk patients. This review also discusses current research limitations and future directions. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of multimodal MRI in acupuncture for post-stroke cognitive impairment]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.015</link>
<description><![CDATA[Post-stroke cognitive impairment (PSCI) is a common complication of stroke and is characterized by deficits in memory, attention, executive function, and other cognitive domains. Acupuncture has shown potential benefits in improving cognitive function after stroke; however, its central mechanisms remain to be further clarified. Multimodal MRI enables non-invasive, quantitative assessment of brain structural, functional, and metabolic changes, thereby providing objective neuroimaging evidence for elucidating the mechanisms of acupuncture in PSCI. This review focuses on recent advances in the application of resting-state functional magnetic resonance imaging (rs-fMRI), diffusion tensor imaging (DTI), arterial spin labeling (ASL), and magnetic resonance spectroscopy (MRS) as the main MRI modalities in studies of acupuncture for PSCI, and briefly discusses voxel-based morphometry (VBM) as a supplementary imaging approach for characterizing gray matter morphological changes and structural pathological features in PSCI. Current evidence suggests that acupuncture may improve cognitive function by modulating large-scale brain networks, enhancing functional connectivity among cognition-related regions, improving white matter microstructural integrity, regulating cerebral metabolism, and improving cerebral perfusion and modulating neurovascular-unit-related changes. These imaging findings indicate that the therapeutic effects of acupuncture on PSCI may involve coordinated regulation of functional networks, structural connectivity, metabolic homeostasis, cerebral perfusion, and neurovascular-unit-related changes. The relationship between imaging changes and clinical cognitive outcomes is also discussed. Nevertheless, existing studies are still limited by small sample sizes, heterogeneous acupuncture protocols, and insufficient multimodal data integration. Future studies should incorporate standardized acupuncture interventions, longitudinal follow-up, and multimodal imaging fusion to further clarify the neural mechanisms and clinical value of acupuncture in PSCI. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advancements in diffusion kurtosis imaging for assessing microstructural alterations in the brain associated with Parkinson<sup><sup>,</sup></sup>s disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.016</link>
<description><![CDATA[Parkinson<sup><sup>,</sup></sup>s disease (PD) has insidious early manifestations, and conventional magnetic resonance imaging (MRI) is limited in detecting brain microstructural abnormalities. Therefore, sensitive and noninvasive imaging methods are urgently needed for early identification and disease assessment. Diffusion kurtosis imaging (DKI) can quantify the non-Gaussian diffusion characteristics of water molecules and sensitively reflect the complexity and heterogeneity of brain tissue microstructure, showing important value in recent studies of PD-related brain microstructural changes. However, current findings remain inconsistent because of differences in sample size, disease stage, clinical subtype, scanning protocols, and post-processing methods, highlighting the need for a systematic review. This article first outlines the technical principles and major parameters of DKI, and then focuses on its applications in gray matter nuclei, white matter fiber tracts, neural circuits, and the glymphatic system in PD. The potential value of DKI combined with artificial intelligence (AI) in auxiliary diagnosis and clinical phenotyping is also discussed. Finally, this review analyzes the current research limitations and future directions, aiming to provide references for the in-depth research and clinical application of DKI in PD. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of magnetic resonance imaging technology in the neuromechanisms of chronic pain associated with pain-related emotions]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.017</link>
<description><![CDATA[Chronic pain is frequently accompanied by negative emotional disturbances such as depression and anxiety, and the interaction between pain and emotion forms a complex vicious cycle that imposes a substantial burden on both patients and society. At present, the clinical assessment of pain-emotion interaction mainly relies on subjective rating scales and symptomatic characteristics, which limits the understanding of its underlying neurobiological mechanisms and the development of precise interventions. In recent years, MRI has become an important noninvasive tool for investigating the central mechanisms of pain-emotion interaction because of its multiparametric imaging advantages. However, several limitations remain, including the lack of standardized individualized imaging thresholds, the limited ability of single-modality imaging to comprehensively characterize complex brain function, insufficient longitudinal causal studies, and inadequate validation in multicenter studies with large sample sizes. This review summarizes recent advances in the application of structural magnetic resonance imaging (sMRI), functional magnetic resonance imaging (fMRI), and brain perfusion/metabolic imaging techniques in chronic pain with pain-emotion interaction. Furthermore, future research directions are discussed, including the integration of machine learning and multicenter radiomics, the development of multimodal imaging fusion techniques, longitudinal follow-up studies, and the establishment of standardized imaging protocols. These advances may provide valuable imaging evidence for elucidating the neural mechanisms of chronic pain with pain-emotion interaction and for promoting precision clinical interventions. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on negative functional connectivity between the default mode network and dorsal attention network in subjective cognitive decline]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.018</link>
<description><![CDATA[Subjective cognitive decline (SCD), as a preclinical stage of Alzheimer<sup><sup>,</sup></sup>s disease (AD), is a critical period where early identification is paramount for effective prevention and intervention. However, the current lack of objective and specific diagnostic markers poses a significant challenge to early identification. In recent years, neuroimaging studies have suggested that abnormalities in the negative functional connectivity between the default mode network (DMN) and the dorsal attention network (DAN) may serve as a potential early neural marker. However, existing research findings are inconsistent, and no systematic synthesis of these findings has been conducted. Therefore, there is an urgent need for a review to integrate current progress and clarify future directions. This review focuses on the physiological basis of DMN-DAN negative functional connectivity and its alterations in individuals with SCD, synthesizes existing evidence regarding its association with AD pathological biomarkers and cognitive function, and summarizes its research value in differentiating etiologies (e.g., vascular or depression-related cognitive decline) and predicting disease progression. Additionally, it highlights methodological challenges in current research, such as participant heterogeneity and the lack of unified analytical standards, and looks ahead to future research directions including the integration of multimodal imaging and artificial intelligence. This review aims to summarize the current state and controversies in this field, providing a theoretical foundation for the development of early biomarkers based on brain network connectivity features. Ultimately, it seeks to guide clinical practice and enhance early screening, precise subtyping, and intervention efficacy for SCD. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in structural and functional MRI studies of deep nuclei in Parkinson<sup><sup>,</sup></sup>s disease patients]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.019</link>
<description><![CDATA[Parkinson<sup><sup>,</sup></sup>s disease is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra and abnormal aggregation of α-synuclein. Deep brain nuclei, such as the subthalamic nucleus, globus pallidus, and substantia nigra, play critical roles in motor control, and their structural and functional abnormalities are key contributors to the symptoms of Parkinson<sup><sup>,</sup></sup>s disease. In recent years, the rapid advancement of MRI techniques, especially high-field MRI, diffusion tensor imaging, and resting-state functional MRI, has provided powerful tools for in vivo, non-invasive investigation of the microstructure, white matter connectivity, and functional network activity of deep brain nuclei in Parkinson<sup><sup>,</sup></sup>s disease patients. This review summarizes recent progress in structural and functional MRI studies of deep brain nuclei in Parkinson<sup><sup>,</sup></sup>s disease, focusing on findings related to volume, morphology, iron deposition, white matter integrity, and abnormalities in local brain activity and network connectivity. It also discusses the correlations between these imaging alterations and disease stages, clinical symptoms (such as bradykinesia, tremor, and gait disturbances), and non-motor symptoms of Parkinson<sup><sup>,</sup></sup>s disease. The review also analyzes current technical limitations in MRI studies of deep brain nuclei and, in light of emerging trends in neuroimaging, identifies future research directions, thereby providing imaging-based theoretical foundations and research references for exploring the pathogenesis of Parkinson<sup><sup>,</sup></sup>s disease, enabling precise diagnosis and treatment, and guiding targeted interventions. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on MRI of the comorbidity between depression and gastrointestinal abnormalities]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.020</link>
<description><![CDATA[Major depressive disorder (MDD) is a leading cause of psychological and physical disability worldwide and a major contributor to the global disease burden. MDD is highly comorbid with gastrointestinal (GI) abnormalities, and patients with GI symptoms (GI-MDD) exhibit more severe clinical profiles than those without (NGI-MDD), particularly with respect to suicidality and anxiety. The neurobiological mechanisms underlying this comorbidity are complex and likely involve multifaceted interactions along the brain-gut axis. Advances in neuroimaging and MRI have opened new avenues for exploring the neural correlates and mechanistic links between MDD and GI disturbances. However, current MRI studies are largely limited by cross-sectional designs, small sample sizes, and insufficient adjustment for confounding factors. In addition, the integration of multi-omics data with multimodal neuroimaging remains scarce, which constrains efforts to clarify the causal architecture of bidirectional brain-gut interactions. This review synthesizes current MRI evidence on structural, functional, and network-level brain alterations in GI-MDD, and further extends the scope to neuroimaging findings in functional gastrointestinal disorders and inflammatory bowel disease with comorbid depression. From a brain-gut axis perspective, we highlight shared and distinct central alterations across these conditions and critically appraise key methodological limitations in the literature. Finally, we outline future directions, including longitudinal designs, large-scale multi-center validation, and integrative approaches incorporating microbiome and metabolomics data. These efforts may ultimately deepen our mechanistic understanding of the comorbidity and inform clinical decision-making, prognostic assessment, and the design of future investigations. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in MRI and radiomics for pituitary neuroendocrine tumors under the new WHO classification]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.021</link>
<description><![CDATA[Pituitary neuroendocrine tumors (PitNETs) are common intracranial neoplasms whose subtypes exhibit varied imaging features. Accurate subtyping and imaging evaluation are therefore critical for individualized treatment planning and prognostic assessment. The fifth edition of the World Health Organization (WHO) Classification of Endocrine and Neuroendocrine Tumors has established a novel molecular subtyping framework centered on cell lineage-specific transcription factors, imposing higher demands on preoperative diagnosis. However, most existing studies remain based on hormonal classification, and a systematic review structured around this updated taxonomy is still lacking, limiting its  ability to meet clinical needs for precision medicine. Accordingly, this article provides a comprehensive review of recent advances in conventional MRI and multiparametric MRI-based radiomics for PitNETs, organized according to the new WHO classification framework. The roles of these imaging approaches in evaluating tumor invasiveness and consistency and in predicting prognosis are discussed, and relevant findings from functional MRI studies are briefly incorporated. Current challenges and future directions are further analyzed, with the aim of providing a reference for precision diagnosis and treatment of PitNETs. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of imaging studies of the patients with coronary microvascular disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.022</link>
<description><![CDATA[Coronary microvascular disease (CMD) is characterized by structural and functional abnormalities of coronary microvessels, leading to angina pectoris and myocardial ischemia. CMD is prevalent in a variety of cardiovascular diseases and is closely associated with poor prognosis in patients. Accordingly, early evaluation of CMD carries substantial clinical significance. However, no current imaging modality can directly visualize the coronary microvascular architecture or microcirculatory flow dynamics. The assessment of CMD predominantly relies on the quantification of myocardial blood flow. Various imaging modalities each have their own advantages and limitations in the assessment of CMD. This article reviews the applications and research advances of multimodal imaging approaches in the quantitative evaluation, diagnosis, and prognosis prediction of CMD, and addresses the limitations of current studies, and propose future research directions. This article aims to summarize the multimodal imaging evidence of CMD, so as to provide references for clinical practice and related research. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in MRI omics and multi-omics in the study of breast cancer tumor microenvironment]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.023</link>
<description><![CDATA[The breast cancer tumor microenvironment is composed of immune cells, fibroblasts, extracellular matrix, vasculature, and other components, and plays a critical role in tumor initiation and progression, therapeutic response, and prognosis. Although conventional pathology and single-molecule assays can provide localized information, they are limited in their ability to noninvasively, dynamically, and comprehensively characterize the heterogeneity of the tumor microenvironment. In recent years, magnetic resonance imaging radiomics, based on multiparametric imaging and high-throughput feature extraction, has made substantial progress in characterizing the breast cancer microenvironment. Meanwhile, advances in genomics, transcriptomics, proteomics, and metabolomics have provided important support for elucidating the associations between imaging phenotypes and underlying molecular mechanisms. However, current studies still face several challenges, including small sample sizes, insufficient standardization, limited model generalizability, and difficulties in multi-omics integration, and comprehensive systematic reviews in this area remain scarce. This review focuses on the key components and biological processes of the breast cancer tumor microenvironment, summarizes the applications of magnetic resonance imaging radiomics in assessing the immune microenvironment, stromal remodeling, angiogenesis, and treatment response, and further reviews the current status of integrative analyses combining radiomics with genomics, transcriptomics, proteomics, and pathomics. The aim is to synthesize the major findings and challenges in this field, clarify the potential value of multi-omics synergy for precise evaluation of the breast cancer tumor microenvironment, and provide references for future research and clinical translation. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The application progress of radiomics in intrahepatic cholangiocarcinoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.024</link>
<description><![CDATA[Intrahepatic cholangiocarcinoma (ICC) is a highly malignant and poorly prognostic subtype of primary liver cancer, and its conventional imaging assessment is challenging. In recent years, radiomics technology has been increasingly applied in the field of ICC, providing new methods for the diagnosis and treatment of this disease. Most existing reviews have not deeply associated radiomics features with the specific biological behaviors of ICC. Therefore, this article aims to systematically summarize the research progress of radiomics in the diagnosis and treatment of ICC, explore the relationship between radiomics features and the biological behaviors of ICC, and provide new ideas for future basic and clinical translational research. Radiomics has demonstrated application value in the differential diagnosis, pathological grading, invasiveness assessment, and postoperative recurrence and survival prediction of ICC. However, current studies generally face challenges such as significant data heterogeneity, poor feature reproducibility, lack of multi-center validation, and limited biological interpretability. Future research needs to develop in the directions of prospective, multi-center, standardized, and multi-modal, integrating radiomics with genomics, pathology, and other fields to construct more robust and practical auxiliary decision-making tools. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Progress of MRI-based radiomics in predicting aggressive phenotypes and evaluating individualized treatment decisions for hepatocellular carcinoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.025</link>
<description><![CDATA[Hepatocellular carcinoma (HCC) is characterized by insidious onset and high biological heterogeneity. Precise prediction of aggressive tumor phenotypes and the formulation of individualized treatment strategies are essential. MRI, with its advantages of multi-parametric imaging, high soft-tissue contrast, and lack of ionizing radiation, combined with radiomics technology for high-throughput quantitative feature extraction, enables the non-invasive disclosure of underlying histopathological and physiological information. This article systematically reviews the latest research progress of MRI-based radiomics in predicting aggressive phenotypes and evaluating individualized treatment decisions for HCC. In particular, the application value of MRI-based radiomics in quantifying intratumoral heterogeneity, predicting aggressive phenotypes such as vessels encapsulating tumor clusters (VETC) and microvascular invasion (MVI), and identifying histopathological grading is discussed. Furthermore, the clinical significance of this technology in evaluating the prognosis of surgical resection and liver transplantation, as well as the efficacy of locoregional and systemic therapies, is summarized. Although MRI-based radiomics has demonstrated significant potential in predicting aggressive phenotypes and evaluating individualized treatment decisions for HCC, limitations such as retrospective single-center designs, limited sample sizes, lack of standardized feature extraction protocols, and restricted clinical interpretability of deep learning models remain. Future research should focus on multi-center prospective studies, deep integration of multi-modal data, and enhancement of algorithmic interpretability to promote the substantial translation of MRI-based radiomics into robust clinical decision support systems. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on radiomics-based precise subtyping and risk stratification of intrahepatic cholangiocarcinoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.026</link>
<description><![CDATA[Intrahepatic cholangiocarcinoma (ICC) is a highly malignant type of primary liver cancer characterized by a high risk of recurrence. This tumor exhibits significant heterogeneity, which profoundly influences patient prognosis and therapeutic response. Radiomics enables the non-invasive quantification of microscopic tumor features. By integrating multidimensional data, including pathological and genomic information, predictive models can be constructed to assist in diagnosis, targeted therapy, and surgical planning. Current research is predominantly retrospective, and a lack of standardized criteria for tumor subregional segmentation often leads to indirect biological interpretation of features. Future efforts should focus on integrating multimodal imaging with deep learning to elucidate the biological significance of the peritumoral microenvironment. Furthermore, multi-center prospective studies are essential to enhance model generalizability. This review summarizes the latest advancements in deciphering the pathological subtypes, molecular characteristics, and invasiveness of ICC using radiomics, offering new perspectives for achieving non-invasive risk stratification and personalized treatment. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on preoperative prediction of endometrial carcinoma molecular subtypes based on MRI radiomics and deep learning]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.027</link>
<description><![CDATA[The incidence of endometrial carcinoma (EC) continues to rise with a younger onset trend. Molecular typing serves as the core basis for precise diagnosis, individualized treatment and prognostic evaluation of EC and has been included in authoritative clinical guidelines. Conventional invasive biopsy is constrained by limited sampling coverage and clinical contraindications, making it incapable of achieving comprehensive and non-invasive evaluation of the integral molecular characteristics of tumors. As the essential preoperative imaging modality for EC, magnetic resonance imaging (MRI), in combination with radiomics and deep learning technologies, can excavate high-order subtle imaging features that are unrecognizable to the naked eye and establish non-invasive associations between imaging phenotypes and tumor molecular pathologies, thereby providing a novel pathway for preoperative molecular typing. This article systematically reviews recent frontier studies worldwide, summarizes the application progress of MRI-based artificial intelligence technologies in the preoperative prediction of four molecular subtypes of EC, compares the diagnostic performance and application advantages of traditional radiomics, deep learning and multimodal fusion models, and analyzes the underlying imaging-pathological correlation mechanisms of different subtypes. Nevertheless, current research still has prominent deficiencies. Most existing studies are single-center and retrospective, with a lack of unified standardized protocols, resulting in insufficient repeatability and generalizability of predictive models. Moreover, the poor interpretability of artificial intelligence models greatly impedes clinical transformation and practical application. By overviewing existing research findings and unresolved limitations, this review prospects future research directions involving multicenter prospective studies, explainable artificial intelligence and multidimensional model fusion, aiming to provide a reference for the clinical translation of non-invasive preoperative molecular typing and precision diagnosis and treatment of EC. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of magnetic resonance elastography in uterine tumors]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.028</link>
<description><![CDATA[Magnetic resonance elastography (MRE) is a non-invasive quantitative biomechanical imaging technique that assesses the mechanical properties of tissues, such as elasticity and viscosity. In recent years, MRE has been increasingly investigated in uterine fibroids, endometrial cancer, and cervical cancer, demonstrating its potential value in differentiating benign from malignant lesions and evaluating tumor aggressiveness. However, most studies are limited to small-sample explorations, lacking systematic summaries and integrated analyses of clinical application prospects. This article systematically reviews the imaging principles of MRE and its clinical application progress in common uterine tumors, analyzes its advantages and limitations, and discusses future directions, aiming to provide a theoretical reference and practical guidance for the use of MRE in precision imaging assessment of gynecological tumors. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress in quantitative magnetic resonance imaging for assessing muscle tissue in neuromuscular diseases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.07.029</link>
<description><![CDATA[Quantitative magnetic resonance imaging (qMRI) technology has significantly advanced the physiological and pathological assessment of muscle tissue in neuromuscular diseases due to its high soft-tissue resolution and multi-parametric capabilities. Among them, qMRI techniques such as T1 mapping, T2 mapping, Dixon, diffusion tensor imaging (DTI), and magnetic resonance spectroscopy (MRS) can precisely quantify the degree of fat infiltration, edema, and fibrosis in muscle tissue, reveal disease-specific pathological invasion patterns, and provide important quantitative microscopic information for neuromuscular diseases. This review summarizes the technical principles of qMRI and its emerging applications in neuromuscular degenerative diseases such as Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), and amyotrophic lateral sclerosis (ALS), systematically compares the pathological sensitivity and clinical efficacy of five core qMRI modalities, and proposes an imaging technology optimization strategy based on clinical needs (encompassing early diagnosis, therapeutic effect monitoring, prognosis prediction).Ultimately, this work provides a systematic literature review and viewpoint integration for the precise imaging management of neuromuscular diseases. ]]></description>
<pubDate>Mon,20 Jul 2026 00:00:00  GMT</pubDate>
</item>
</channel>
</rss>
